Efficacy and safety of a novel hemostatic peptide solution during endoscopic submucosal dissection: a multicenter randomized controlled trial.

Masashi NamikawaNoriya UedoTsuneo OyamaYutaka SaitoNaohisa YahagiAi FujimotoYoshiro KawaharaKatsuhiro MabeTakuto HikichiYorimasa YamamotoHisao Tajiri

Published in: The American journal of gastroenterology (2022)

TDM-621 is a useful, easily operable hemostatic peptide for treatment of blood oozing during gastric and rectal ESDs, with no serious safety concerns.

Keyphrases

endoscopic submucosal dissection
randomized controlled trial
study protocol
rectal cancer
systematic review
clinical trial
combination therapy